Keurig Dr Pepper Inc (NYSE:KDP) Director Robert S. Singer purchased 3,000 shares of the stock in a transaction on Tuesday, August 13th. The stock was acquired at an average price of $28.65 per share, with a total value of $85,950.00. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Shares of NYSE:KDP traded down $0.15 during trading on Tuesday, reaching $28.47. 2,027,623 shares of the stock were exchanged, compared to its average volume of 2,573,619. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.23 and a current ratio of 0.33. Keurig Dr Pepper Inc has a 12-month low of $22.19 and a 12-month high of $31.06. The firm has a market capitalization of $40.92 billion, a price-to-earnings ratio of 27.38, a price-to-earnings-growth ratio of 1.55 and a beta of 0.46. The company has a 50-day moving average price of $28.64.

Keurig Dr Pepper (NYSE:KDP) last issued its earnings results on Thursday, August 8th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.29 by $0.01. Keurig Dr Pepper had a return on equity of 7.15% and a net margin of 8.82%. The business had revenue of $2.81 billion during the quarter, compared to analysts’ expectations of $2.86 billion. During the same quarter in the previous year, the business earned $1.30 EPS. The company’s revenue for the quarter was up 196.3% on a year-over-year basis. On average, analysts expect that Keurig Dr Pepper Inc will post 1.22 earnings per share for the current fiscal year.

KDP has been the subject of several recent analyst reports. Credit Suisse Group initiated coverage on Keurig Dr Pepper in a report on Wednesday, July 17th. They issued a “neutral” rating and a $27.00 price target for the company. Zacks Investment Research upgraded Keurig Dr Pepper from a “hold” rating to a “buy” rating and set a $32.00 price target for the company in a report on Wednesday, June 19th. Morgan Stanley set a $24.00 price target on Keurig Dr Pepper and gave the company a “sell” rating in a report on Friday. Royal Bank of Canada set a $31.00 price target on Keurig Dr Pepper and gave the company a “buy” rating in a report on Friday. Finally, Bank of America lifted their price target on Keurig Dr Pepper from $30.00 to $33.00 and gave the company a “buy” rating in a report on Friday. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the stock. Keurig Dr Pepper presently has a consensus rating of “Buy” and a consensus target price of $29.24.

Several large investors have recently modified their holdings of the company. Parallel Advisors LLC grew its holdings in shares of Keurig Dr Pepper by 30.8% during the 1st quarter. Parallel Advisors LLC now owns 2,317 shares of the company’s stock worth $65,000 after purchasing an additional 546 shares during the period. Rathbone Brothers plc grew its holdings in shares of Keurig Dr Pepper by 1.3% during the 1st quarter. Rathbone Brothers plc now owns 55,201 shares of the company’s stock worth $1,544,000 after purchasing an additional 694 shares during the period. Charter Trust Co. grew its holdings in shares of Keurig Dr Pepper by 8.9% during the 1st quarter. Charter Trust Co. now owns 8,766 shares of the company’s stock worth $245,000 after purchasing an additional 720 shares during the period. CIBC Asset Management Inc lifted its position in Keurig Dr Pepper by 8.0% during the 1st quarter. CIBC Asset Management Inc now owns 9,793 shares of the company’s stock worth $274,000 after acquiring an additional 726 shares in the last quarter. Finally, MRA Associates USA LLC acquired a new position in Keurig Dr Pepper during the 2nd quarter worth approximately $25,000. Institutional investors and hedge funds own 14.15% of the company’s stock.

About Keurig Dr Pepper

Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.

See Also: How Important is Technical Analysis of Stocks

Insider Buying and Selling by Quarter for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.